MarketNeisseria gonorrhoeae
Company Profile

Neisseria gonorrhoeae

Neisseria gonorrhoeae, also known as gonococcus (singular) or gonococci (plural), is a species of Gram-negative diplococci bacteria first isolated by Albert Neisser in 1879. An obligate human pathogen, it primarily colonizes the mucosal lining of the urogenital tract; however, it is also capable of adhering to the mucosa of the nose, pharynx, rectum, and conjunctiva. It causes the sexually transmitted genitourinary infection gonorrhea as well as other forms of gonococcal disease including disseminated gonococcemia, septic arthritis, and gonococcal ophthalmia neonatorum.

Microbiology
Neisseria species are fastidious, Gram-negative cocci (though some species are rod-shaped and occur in pairs or short chains) that require nutrient supplementation to grow in laboratory cultures. They are facultative intracellular pathogens, meaning they can persist and colonize within host cells but can also multiply outside the host cellular environment. They typically appear in pairs (diplococci), resembling the shape of coffee beans. most are also obligate aerobes. Of the 17 species that colonize humans, only two are pathogenic: N. gonorrhoeae, which causes gonorrhea, and N. meningitidis, a leading cause of bacterial meningitis. Culture and identification ) can be used to differentiate N. gonorrhoeae from N. meningitidis.q N. gonorrhoeae can be isolated on Thayer–Martin agar (or VPN) agar in an atmosphere enriched with 3-7% carbon dioxide. Thayer–Martin agar is a chocolate agar plate (heated blood agar) containing nutrients and antimicrobials (vancomycin, colistin, nystatin, and trimethoprim). This agar preparation facilitates the growth of Neisseria species while inhibiting the growth of contaminating bacteria and fungi. Martin Lewis and New York City agar are other types of selective chocolate agar commonly used for Neisseria growth. N. gonorrhoeae is oxidase positive (possessing cytochrome c oxidase) and catalase positive (able to convert hydrogen peroxide to oxygen). When incubated with the carbohydrates lactose, maltose, sucrose, and glucose, N. gonorrhoeae will oxidize only the glucose. == Metabolism ==
Metabolism
Carbon Unlike other Neisseria species that can also metabolize maltose, N. gonorrhoeae is capable of using only glucose, pyruvate, and lactate as central carbon sources, and glucose is catabolized via both the Entner-Doudoroff (ED) and pentose phosphate (PP) pathways, and the ED pathway is the primary oxidative method. Use of these pathways is necessary as N. gonorrhoeae is incapable of glucose catabolism via the Embden-Meyerhof-Parnas (EMP) pathway due its lack of the phosphofructokinase (PFK) gene; however, the fructose 1,6-bisphosphatase enzyme is present to allow for gluconeogenesis to occur. The resultant pyruvate molecules are then converted into acetyl-CoA, which can then be incorporated as a substrate for the citric acid cycle (CAC) to yield high-energy electron carriers that will be used by the electron transport chain (ETC) for ATP production; however, the CAC is largely used for generating biosynthetic precursors rather than for catabolic purposes. This is due in part to inhibited expression of several CAC enzymes in the presence of glucose, pyruvate, or lactate. These enzymes, namely citrate synthase, aconitase, and isocitrate dehydrogenase, are needed for the incorporation of acetate. Instead, a partial CAC has been observed, where α-ketoglutarate is formed by glutamate dehydrogenase or transamination of oxaloacetate and glutamate by aspartate aminotransferase (yielding aspartate and α-ketoglutarate). While this acetate can enter the CAC for further oxidation, this does not occur so long as other carbon sources such as glucose or lactate are present, in which case it is excreted from the cell or incorporated for lipid synthesis. N. gonorrhoeae lack the glyoxylate shunt, preventing them from using acetate to form CAC intermediates to replenish the cycle. The membrane-bound LDHs have been determined to be flavoprotein-containing respiratory enzymes that directly oxidize lactate to reduce ubiquinone. While these enzymes do not directly pump protons (H+ ions) into the periplasmic space, it is proposed that the reduction of ubiquinone by these enzymes is capable of feeding into the larger ETC. Several enzymes contribute electrons to the intramembranous ubiquinone pool, the first step in the ETC. These include the membrane-bound LDHs (LldD and LdhD), NADH:ubiquinone oxidoreductase (aka NADH dehydrogenase; Nuo complex I), Na+-translocating NADH dehydrogenase (Nqr), succinate dehydrogenase (SDH), and the membrane-bound NAD+-independent malate:quinone-oxidoreductase (MqR). In the case of the former, electrons can then be passed from the bc1 complex along two alternative pathways via the reduction of either cytochrome c4 or c5. Both of these cytochromes transfer electrons to the terminal cytochrome ccb3 oxidase for the reduction of O2 to form H2O under aerobic conditions. The general purpose of the ETC is the formation of the electrochemical gradient of hydrogen ions (H+ or protons), resulting from concentration differences across the plasma membrane, needed to power ATP production in a process known as oxidative phosphorylation. In gonococci, movement of protons into the periplasmic space is accomplished by the Nuo complex I, the cytochrome bc1 complex, and cytochrome ccb3. Subsequently, ATP synthesis is performed by the F1F0 ATP synthase, a two-part protein complex present in gonococci as well as numerous other species across phylogenetic domains. This complex couples proton translocation back into the cytoplasm along its gradient with mechanical rotation to generate ATP. Iron The general purpose of the ETC is the formation of the electrochemical gradient of hydrogen ions (H+ or protons), resulting from concentration differences across the plasma membrane, needed to power ATP production in a process known as oxidative phosphorylation. Along with the sequestration defence that can be further upregulated by host inflammation, humans also produce siderocalins that can chelate siderophores as a further method of inhibiting pathogenic bacterial growth. These are sometimes ineffective against N. gonorrhoeae, which can colonize intracellularly, particularly in phagocytic cells such as macrophages and neutrophils. Increases in host intracellular iron also downregulate some of the intracellular pathogen-killing mechanisms; coincidentally, pathogenic Neisseria can alter several host cell mechanisms that ultimately allow the pathogen to take most of the available iron from the host immune cell. Opa proteins Phase-variable opacity-associated (Opa) adhesin proteins are used by N. gonorrhoeae as part of evading the immune response in a host cell. At least 12 Opa proteins are known, and the many variations of surface proteins make recognizing N. gonorrhoeae and mounting a defense by immune cells more difficult. Opa proteins are in the outer membrane and facilitate a response when the bacteria interacts with a variety of host cells. These proteins bind to various epithelial cells, and allow N. gonorrhoeae to increase the length of infection as well as increase the amount of invasion into other host cells. Type IV pili Dynamic polymeric protein filaments called type IV pili allow N. gonorrhoeae to do many bacterial processes, including adhesion to surfaces, transformation competence, twitching motility, and immune response evasions. To enter the host the bacteria uses the pili to adhere to and penetrate mucosal surfaces. The pili are a pivotal virulence factor for N. gonorrhoeae; without them, the bacterium is unable to promote colonization. For motility, individual bacteria use their pili in a manner that resembles a grappling hook: first, they are extended from the cell surface and attach to a substrate. Subsequent pilus retraction drags the cell forward. The resulting movement is referred to as twitching motility. N. gonorrhoeae can pull 100,000 times its own weight, and the pili used to do so are amongst the strongest biological motors known to date, exerting one nanonewton. This process allows N. gonorrhoeae to recombine its genes and alter the antigenic determinants that adorn its surface, Simply stated, the chemical composition of molecules are changed due to changes at the genetic level. In addition to gene rearrangement, it is also naturally competent, meaning it can acquire extracellular DNA from the environment via its type IV pilus, specifically proteins PilQ and PilT. These processes allow N. gonorrhoeae to acquire and spread new genes, disguise itself with different surface proteins, and prevent the development of immunological memory – an ability which has contributed to antibiotic resistance and impeded vaccine development. Phase variation Phase variation is similar to antigenic variation, but instead of changes at the genetic level altering the composition of molecules, these genetic changes result in the activation or deactivation of a gene. However, a significant fraction of the gonococci can resist killing through the action of their catalase, The bacterial RecA protein, which mediates repair of DNA damage, plays a crucial role in gonococcal survival. N. gonorrhoeae may replace DNA damaged in neutrophil phagosomes with DNA from neighboring gonococci. The process in which recipient gonococci integrate DNA from neighboring gonococci into their genome is called transformation. == Genome ==
Genome
The genomes of several strains of N. gonorrhoeae have been sequenced. Most of them are about 2.1 Mb in size and encode 2,100 to 2,600 proteins (although most seem to be in the lower range). For instance, strain NCCP11945 consists of one circular chromosome (2,232,025 bp) encoding 2,662 predicted open reading frames (ORFs) and one plasmid (4,153 bp) encoding 12 predicted ORFs. The estimated coding density over the entire genome is 87%, and the average G+C content is 52.4%, values that are similar to those of strain FA1090. The NCCP11945 genome encodes 54 tRNAs and four copies of 16S-23S-5S rRNA operons. Horizontal gene transfer Horizontal gene transfer, also termed lateral gene transfer, is the sharing of genetic information amongst living organisms. This transmission of information is a driving force of antibiotic resistance in N. gonorrhoeae. Studies have identified that N. gonorrhoeae has obtained methods of antimicrobial resistance by way of horizontal gene transfer from other Neisseria species including N. lactamica, N. macacae, and N. mucosa. Transformation in N. gonorrhoeae is performed by the type IV pilus, where the DNA is bound and brought into the cell, followed by processing and homologous recombination. Found in some genomes of Neisseria gonorrhoeae, the gonococcal genetic island (GGI), a genomic island (GI) specific to gonococci, has been identified as a mobile genetic element that is horizontally acquired. GGI is involved with antimicrobial resistance, transmission of genetic information, and iron acquisition. In 2011, researchers at Northwestern University found evidence of a human DNA fragment in a N. gonorrhoeae genome, the first example of horizontal gene transfer from humans to a bacterial pathogen. == Disease ==
Disease
Symptoms Symptoms of infection with N. gonorrhoeae differ depending on the site of infection and many infections are asymptomatic independent of sex. Depending on the route of transmission, N. gonorrhoeae may cause infection of the throat (pharyngitis) or infection of the anus/rectum (proctitis). If untreated, scarring of the urethra may result in difficulty urinating. Infection may spread from the urethra in the penis to nearby structures, including the testicles (epididymitis/orchitis), or to the prostate (prostatitis). Female In symptomatic women, the primary symptoms of genitourinary infection are increased vaginal discharge, burning with urination (dysuria), increased urge to urinate, pain with intercourse, or menstrual abnormalities. Pelvic inflammatory disease results if N. gonorrhoeae ascends into the pelvic peritoneum (via the cervix, endometrium, and fallopian tubes). The resulting inflammation and scarring of the fallopian tubes can lead to infertility and an increased risk of ectopic pregnancy. Gonococcal ophthalmia neonatorum, once common in newborns, is prevented by the application of erythromycin (antibiotic) gel to the eyes of babies at birth as a public health measure. Silver nitrate is no longer used in the United States. Traditionally, the bacterium was thought to move attached to spermatozoa, but this hypothesis did not explain female-to-male transmission of the disease. A recent study suggests that rather than "surf" on wiggling sperm, N. gonorrhoeae bacteria use pili to anchor onto proteins in the sperm and move through coital fluid. Infection Successful transmission is followed by adherence to the epithelial cells found at the infected mucosal site by the bacterium's type IV pili. The pili's ability to attach and subsequently retract pulls N. gonorrhoeae towards the epithelial membrane at the surface of the mucosal cell. Other methods of detection include microscopy and culture. Condoms and dental dams should be used during oral and anal sex as well. Spermicides, vaginal foams, and douches are not effective methods for transmission prevention. There are problems that have hampered vaccine development including: the absence of immunity post-infection, exclusively human hosts, and antigenic and phase variation of potential vaccine targets. Currently, there are several N. gonorrhoeae vaccines in development, including an outer membrane vesicle vaccine. The creation of a vaccine for N. gonorrhoeae has several potential public health impacts. In one estimate, a vaccine for the heterosexual population given before sexual activity occurs showed that the prevalence of N. gonorrhoeae could be reduced by up to 90% after 20 years. . NHS England has also launched the world's first vaccination program against gonorrhea, using a vaccine against Neisseria meningitidis which was found to be partially effective against N. gonorrhoeae . Treatment Currently, the CDC recommends a single dose of the injectable cephalosporin, ceftriaxone, as the first line of defense against gonococcal infections. Individuals weighing less than 150 kg are typically prescribed a ceftriaxone concentration of 500 mg, while individuals who weigh over 150 kg are typically prescribed a dose of 1 g. Although ceftriaxone is not the only cephalosporin that has been effective at treating gonorrhoeae, it is the most advantageous. Antibiotic resistance Antibiotic resistance in gonorrhea was first identified in the 1940s. Gonorrhea was treated with penicillin, but doses had to be progressively increased to remain effective. By the 1970s, penicillin-and tetracycline-resistant gonorrhea emerged in the Pacific Basin. These resistant strains then spread to Hawaii, California, the rest of the United States, Australia and Europe. Fluoroquinolones were the next line of defense, but soon resistance to this antibiotic emerged, as well. Since 2007, standard treatment has been third-generation cephalosporins, such as ceftriaxone, which are considered to be our "last line of defense". Recently, a high-level ceftriaxone-resistant strain of gonorrhea called was discovered in Japan. Lab tests found it to be resistant to high concentrations of ceftriaxone, as well as most of the other antibiotics tested. Within N. gonorrhoeae, genes exist that confer resistance to every single antibiotic used to cure gonorrhea, but thus far, they do not coexist within a single gonococcus. However, because of N. gonorrhoeaes high affinity for horizontal gene transfer, antibiotic-resistant gonorrhea is seen as an emerging public health threat. Serum resistance As a Gram negative bacterium, N. gonorrhoeae requires defense mechanisms to protect itself against the complement system (or complement cascade), whose components are found with human serum. A cleaved portion of this protein, C3b, is deposited on pathogenic surfaces and results in opsonization as well as the downstream activation of the membrane attack complex. N. gonorrhoeae has several mechanisms to avoid this action. As a whole, these mechanisms are referred to as serum resistance. == History ==
History
Name origin Neisseria gonorrhoeae is named for Albert Neisser, who isolated it as the causative agent of the disease gonorrhea in 1878. After Hunter's experiment other scientists sought to disprove his conclusions by inoculating other male physicians, medical students, == See also ==
tickerdossier.comtickerdossier.substack.com